Onderneming TaiGen Biopharmaceuticals Holdings Limited
Aandelen
4157
KYG866171005
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,3 TWD | -0,33% | +2,00% | +0,66% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Development of Innovative New Drugs
96,8
%
| 36 | 100,0 % | 119 | 96,8 % | +228,87% |
Other
3,2
%
| - | - | 4 | 3,2 % | - |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
75,2
%
| 0 | 0,0 % | 93 | 75,2 % | - |
Taiwan
24,8
%
| 21 | 58,0 % | 31 | 24,8 % | +45,36% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Philip Huang
CEO | Chief Executive Officer | - | 17-12-18 |
Richard Lue
DFI | Director of Finance/CFO | - | 01-04-16 |
Ming-Chu Hsu
BRD | Director/Board Member | - | 01-04-01 |
Hsuan Ju Wang
IRC | Investor Relations Contact | - | - |
MIng Tsung Kao
AUD | Comptroller/Controller/Auditor | - | 16-12-19 |
Chu Chung Lin
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shou-Chuan Ho
BRD | Director/Board Member | - | 29-04-13 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 01-04-13 |
Sheng Fu Yu
BRD | Director/Board Member | 79 | 12-06-19 |
Weng Foung Huang
BRD | Director/Board Member | - | 24-06-11 |
Kuo-Hsi Wang
BRD | Director/Board Member | - | 03-03-09 |
Ming-Chu Hsu
BRD | Director/Board Member | - | 01-04-01 |
Philip Huang
CEO | Chief Executive Officer | - | 17-12-18 |
Yen Hua Huang
BRD | Director/Board Member | - | 31-12-07 |
Yeh Hung Chang
BRD | Director/Board Member | - | 12-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 717 844 175 | 358 926 175 ( 50,00 %) | 0 | 50,00 % |
Bedrijfsgegevens
TaiGen Biopharmaceuticals Holdings Ltd.
7th Floor No. 138 Shinming Road
114 70, Taipei
+
http://www.taigenbiotech.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,66% | 338 mln. | |
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers 4157
- Onderneming TaiGen Biopharmaceuticals Holdings Limited